Sonablate offers a minimally-invasive treatment using High-Intensity Focused Ultrasound (HIFU) to ablate diseased prostate tissue, providing customizable options for patients.
Founded
2004
Total Funding
$100M+
Total Rounds
1
First Raise
Aug 10, 2026
Latest Raise
Aug 10, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/10/2026 | |||
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free